NVP-AUY-922 is currently in clinical trials in advanced EGFR mutant NSCLC refractory to EGFR TKIs (NCT01646125, NCT01124864), or with an EGFR exon 20 mutation (NCT01854034). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.